CBC library screening POP 9/29/2020 - 9/28/2021
Ended Awarded Last action
- Contract number
- 75N91020F00001
- Awardee
-
Evotec US Inc. UEI LA7FUVX1EZQ7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,376,804
Award facts
- Opportunity
-
- CBCSLC2020E07 Solicitation number
- Contract value 100% obligated
- $1,376,803.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $290,828 | |
| Exercise an Option | $282,378 | |
| Exercise an Option | $276,534 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $268,579 | |
| Original award | $258,485 |
About this award
The National Cancer Institute awarded a delivery order to Evotec US Inc. for the Chemical Biology Consortium Screening Libraries Center, with a ceiling value of $1.38 million and an ultimate completion date of September 28, 2025. This firm fixed-price delivery order, awarded on September 29, 2020, supports the FY26 UDO Initiative and utilizes no set-aside provisions, indicating open competition. Work will be performed at Evotec's facility in South San Francisco, California.
Evotec US Inc., a foreign-owned scientific research services provider, brings substantial expertise in chemical screening and library management to this engagement. The company has established itself as a critical support contractor for the National Cancer Institute and has maintained a robust relationship with the Environmental Protection Agency's Office of Research and Development through multiple awards, including a large IDIQ contract valued at approximately $16.1 million through April 2029. This NCI delivery order complements Evotec's broader portfolio of federal research support, leveraging the company's capabilities in chemical procurement, analysis, sample preparation, and screening library management across multiple federal science agencies.
Quick answers
Who was awarded contract 75N91020F00001?
75N91020F00001 was awarded to Evotec US Inc. by National Cancer Institute (National Institutes of Health) on September 29, 2020.
How much is contract 75N91020F00001 worth?
The government has obligated $1,376,804 on 75N91020F00001.
Is contract 75N91020F00001 an order under another contract?
Yes. 75N91020F00001 is a delivery order under HHSN261201500010I, an indefinite delivery contract.
Was contract 75N91020F00001 competed?
The extent of competition for 75N91020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award